GXH: Response
1
29 September 2021
Response to speculation
Green Cross Health refers to speculation in the Australian media about its participation in a
process to acquire Tamaki Health. Green Cross Health advises that it is working with Pacific
Equity Partners (PEP) in that process, as the media speculates. The process is in its early stages.
The nature and terms of any transaction for the acquisition of Tamaki Health have yet to be
determined. There is no certainty that Green Cross Health will be the successful party or that any
transaction will be concluded.
Green Cross Health confirms it is in compliance with its continuous disclosure obligations.
ENDS
Contact:
Rachael Newfield
rachael.newfield@gxh.co.nz
Ben Doshi
ben.doshi@gxh.co.nz
About Green Cross Health
Green Cross Health (NZX: GXH) is a trusted New Zealand primary healthcare provider
with multidisciplinary healthcare teams with the purpose of working together to support
healthier communities. New Zealand owned and operated, Green Cross Health operates
under branded groups Unichem and Life Pharmacies, The Doctors medical centres, Total
Care Health community nursing services and Access Community Health to provide
support, care and advice to diverse New Zealand communities.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- PEB — Pacific Edge Limited: Response to Media Speculation – ASX Dual Listing2021-09-08
“Company Announcement 9 September 2021 RESPONSE TO MEDIA SPECULATION – ASX DUAL LISTING Pacific Edge is aware of the media commentary relating to its announcement yesterday and it wishes to reconfirm that the information released by ASX is incorrect. Pacific Edge confirms…”
- HGH — Heartland Group Holdings Limited: Substantial holder notice – HGH in HMY2021-07-06
“1 Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 To NZX Limited and To Harmoney Corp Limited Relevant event being disclosed: acquisition of additional…”
- PEB — Pacific Edge Limited: Cxbladder extends DHB coverage2021-07-06
“7 July 2021 CXBLADDER CONTINUES TO WIN OVER NZ PUBLIC HEALTHCARE PROVIDERS Northland District Health Board adopts full suite of Cxbladder tests Cancer diagnostics company, Pacific Edge Limited (NZX: PEB) has reached commercial agreement with Northland Distric…”